XML 94 R81.htm IDEA: XBRL DOCUMENT
v3.6.0.2

SUBSEQUENT EVENTS (Narrative) (Details) | Feb. 14, 2017 USD ($) | Jan. 10, 2017 USD ($) $ / shares | Feb. 06, 2017 USD ($) institution instrument | Dec. 31, 2016 USD ($) instrument $ / shares | Oct. 25, 2016 $ / shares | Jul. 12, 2016 USD ($) | Jun. 22, 2016 instrument | Dec. 31, 2015 $ / shares
--- | --- | --- | --- | --- | --- | --- | --- | ---
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Common stock, par value (in dollars per share) | $ / shares |  |  |  | $ 0.01 | $ 0.01 |  |  | $ 0.01
Interest rate swap |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Derivative, number of instruments | instrument |  |  |  | 3 |  |  |  |
Derivative, notional amount |  |  |  | $ 150,000,000 |  | $ 50,000,000 |  |
Interest rate swap | Designated as hedging instrument | Cash flow hedging |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Derivative, number of instruments | instrument |  |  |  |  |  |  | 2 |
Derivative, notional amount |  |  |  | $ 150,000,000 |  |  |  |
Subsequent Event | Interest rate swap | Designated as hedging instrument | Cash flow hedging |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Derivative, number of instruments | instrument |  |  | 2 |  |  |  |  |
Derivative, number of financial institutions | institution |  |  | 2 |  |  |  |  |
Subsequent Event | Interest Rate Swap Three | Designated as hedging instrument | Cash flow hedging |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Derivative, notional amount |  |  | $ 50,000,000.0 |  |  |  |  |
Subsequent Event | Interest Rate Swap Four | Designated as hedging instrument | Cash flow hedging |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Derivative, notional amount |  |  | $ 100,000,000 |  |  |  |  |
Derma Sciences | Subsequent Event |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Common stock, par value (in dollars per share) | $ / shares |  | $ 0.01 |  |  |  |  |  |
Expected consideration to be transferred |  | $ 207,600,000 |  |  |  |  |  |
DePuy Synthes | Subsequent Event |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Expected consideration to be transferred | $ 1,000,000,000 |  |  |  |  |  |  |
DePuy Synthes | DePuy Synthes | Subsequent Event |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Alternative transaction, percentage of assets (or more) | 25.00% |  |  |  |  |  |  |
Reimbursement expense, if offer not accepted prior to expiration | $ 10,500,000 |  |  |  |  |  |  |
Termination fee, if requirements not met | $ 41,800,000 |  |  |  |  |  |  |
Termination fee due if alternate proposal accepted, period after termination of offer | 12 months |  |  |  |  |  |  |
Common Stock | Derma Sciences | Subsequent Event |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Share price (in dollars per share) | $ / shares |  | $ 7.0 |  |  |  |  |  |
Series A Preferred Stock | Derma Sciences | Subsequent Event |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Share price (in dollars per share) | $ / shares |  | 32.00 |  |  |  |  |  |
Series B Preferred Stock | Derma Sciences | Subsequent Event |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |
Share price (in dollars per share) | $ / shares |  | $ 48.00 |  |  |  |  |  |

X
- Definition Business Combination, Alternative Transaction Threshold, Percentage of Assets + References No definition available. + Details
Name: | iart_BusinessCombinationAlternativeTransactionThresholdPercentageofAssets
Namespace Prefix: | iart_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Contingent Consideration, Potential Termination Fee + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationPotentialTerminationFee
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Business Combination, Expected Consideration To Be Transferred + References No definition available. + Details
Name: | iart_BusinessCombinationExpectedConsiderationToBeTransferred
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Combination, Reimbursement Expense, Offer Not Accepted Prior to Expiration + References No definition available. + Details
Name: | iart_BusinessCombinationReimbursementExpenseOfferNotAcceptedPriortoExpiration
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Business Combination, Termination Fee Due if Alternate Proposal Accepted, Period After Termination of Offer + References No definition available. + Details
Name: | iart_BusinessCombinationTerminationFeeDueifAlternateProposalAcceptedPeriodAfterTerminationofOffer
Namespace Prefix: | iart_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Derivative, Number of Financial Institutions + References No definition available. + Details
Name: | iart_DerivativeNumberofFinancialInstitutions
Namespace Prefix: | iart_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate notional amount specified by the derivative(s). Expressed as an absolute value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 12 -Section 13 -Sentence Column B + Details
Name: | invest_DerivativeNotionalAmount
Namespace Prefix: | invest_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of derivative instruments of a particular group held by the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959 + Details
Name: | us-gaap_DerivativeNumberOfInstrumentsHeld
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References No definition available. + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=iart_InterestRateSwapFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_DePuySynthesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=iart_DePuySynthesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |